Hainan Poly Pharm. Co., Ltd (SHE:300630)
2.490
0.00 (0.00%)
Mar 21, 2025, 3:04 PM CST
Hainan Poly Pharm. Revenue
Hainan Poly Pharm. had revenue of 187.78M CNY in the quarter ending September 30, 2024, with 22.90% growth. This brings the company's revenue in the last twelve months to 1.31B, up 49.91% year-over-year. In the year 2023, Hainan Poly Pharm. had annual revenue of 1.30B, down -19.43%.
Revenue (ttm)
1.31B
Revenue Growth
+49.91%
P/S Ratio
1.06
Revenue / Employee
834.88K
Employees
1,565
Market Cap
1.39B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.30B | -314.65M | -19.43% |
Dec 31, 2022 | 1.62B | 110.30M | 7.31% |
Jan 1, 2022 | 1.51B | 320.23M | 26.94% |
Dec 31, 2020 | 1.19B | 238.51M | 25.10% |
Dec 31, 2019 | 950.10M | 326.19M | 52.28% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Aier Eye Hospital Group | 20.62B |
Shanghai United Imaging Healthcare | 10.30B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |
Sichuan Biokin Pharmaceutical | 5.82B |